Pindolol (Compound)

Synonyms:pindolol, 13523-86-9, Visken, Betapindol, Prinodolol, Carvisken, Durapindol, Pinbetol, Calvisken, Decreten, Pectobloc, Pynastin, LB-46, Blocklin L, Glauco-visken, Pindololum, Blocklin-L, DL-Pindolol, Blockin L, LB 46, (rs)-pindolol, 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol, 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole, 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol, 1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol, Apo-pindol, 1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol, 1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol, 4-(3-(Isopropylamino)-2-hydroxypropoxy)indole, 2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-, Dl-lb-46, 1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol, BJ4HF6IU1D, NSC-757276, 2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-, CHEBI:8214, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol, DTXSID8023476, 2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-, Glauco-Viskin, 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol, NCGC00015786-11, 1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol, 2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-, (+-)-Pindolol, Pindololum [INN-Latin], DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole, DTXCID603476, Blocklin, Carvisken (TN), SMR000059120, Blocklin-L (TN), Visken (TN), CCRIS 9215, HSDB 6539, SR-01000000027, EINECS 236-867-9, EINECS 244-623-8, UNII-BJ4HF6IU1D, BRN 1536506, DL-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE, DL-LB 46, Prestwick_397, CAS-13523-86-9, Pindolol [USAN:USP:INN:BAN:JAN], Spectrum_001109, (-)-Pindolol; (S)-(-)-Pindolol; S-Pindolol, (1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol, PINDOLOL [HSDB], PINDOLOL [USAN], PINDOLOL [INN], PINDOLOL [JAN], PINDOLOL [MI], PINDOLOL [VANDF], (.+/-.)-Pindolol, Prestwick0_000090, Prestwick1_000090, Prestwick2_000090, Prestwick3_000090, Spectrum2_001285, Spectrum3_000547, Spectrum4_000479, Spectrum5_001266, PINDOLOL [MART.], CHEMBL500, GTPL91, PINDOLOL [USP-RS], PINDOLOL [WHO-DD], PINDOLOL,(-), P 0778, P-6820, SCHEMBL5219, Lopac0_000955, Oprea1_770884, (+/-)-PINDOLOL, BSPBio_000020, BSPBio_002193, KBioGR_000958, KBioSS_001589, 5-21-03-00017 (Beilstein Handbook Reference), MLS000069496, MLS002548891, DivK1c_000837, SPECTRUM1500488, Pindolol (JP17/USP/INN), SPBio_001289, SPBio_001959, PINDOLOL [ORANGE BOOK], 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, BPBio1_000022, PINDOLOL [EP MONOGRAPH], 1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol, PINDOLOL [USP MONOGRAPH], HMS502J19, KBio1_000837, KBio2_001589, KBio2_004157, KBio2_006725, KBio3_001693, NINDS_000837, 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-, HMS1568A22, HMS1920H16, HMS2089I21, HMS2091P20, HMS2095A22, HMS3259I07, HMS3262P12, HMS3267K17, HMS3369E14, HMS3414J03, HMS3678H21, HMS3712A22, HMS3742C07, HMS3885N04, Pharmakon1600-01500488, VISKAZIDE COMPONENT PINDOLOL, HY-B0982, Pindolol, >=98% (TLC), powder, Tox21_110221, Tox21_500955, BDBM50019443, CCG-39223, NSC757276, PDSP1_000771, PDSP1_000772, PDSP2_000759, PDSP2_000760, (+/-)-Pindolol-d7(iso-propyl-d7), AKOS015969756, PINDOLOL COMPONENT OF VISKAZIDE, Tox21_110221_1, CS-4473, DB00960, LP00955, NC00467, NSC 757276, SB17015, SDCCGSBI-0050929.P005, IDI1_000837, NCGC00015786-06, NCGC00015786-07, NCGC00015786-08, NCGC00015786-09, NCGC00015786-10, NCGC00015786-13, NCGC00015786-14, NCGC00015786-16, NCGC00015786-20, NCGC00015786-22, NCGC00024925-03, NCGC00024925-04, NCGC00024925-05, NCGC00024925-06, NCGC00024925-07, NCGC00261640-01, BS-42390, SBI-0050929.P004, 4-(3-Isopropylamino-2-hydroxypropoxy)indole, AB00052072, EU-0100955, FT-0673907, SW196641-3, (+/-)-LB-46, C07445, C90604, D00513, AB00052072-11, AB00052072_12, AB00052072_13, 1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol, EN300-18518413, L000006, Q418101, 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)INDOLE, SR-01000000027-2, SR-01000000027-4, SR-01000000027-5, SR-01000000027-7, 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol, BRD-A97701745-001-05-3, BRD-A97701745-001-09-5, 1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol #, Pindolol, European Pharmacopoeia (EP) Reference Standard, (+/-)-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE, 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol), Pindolol, United States Pharmacopeia (USP) Reference Standard, 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol), N-(2-HYDROXY-3-(1H-INDOL-4-YLOXY)PROPYL)-N-ISOPROPYLAMINE
Pubchem:PUBCHEM:4828
Id:20863dbc-d3e4-5cba-9bcd-e84ed239e344
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Pindolol's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Pindolol.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Pindolol.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.